We have analyzed the effect of a patented glycoconjugate of natural origin, AM3 (commercially available under the name Inmunoferon) in the expression of iNOS induced by administration of LPS in mice. We have observed that oral treatment with the drug daily for 6 days reduced the levels of expression of iNOS induced by an intravenous pulse of LPS. This effect was significant in the lungs and kidneys, but it was much more marked in the liver. In addition, the levels of nitric oxide in serum were clearly decreased upon treatment with AM3. Together, these results suggest that AM3 modulates the nitric oxide response and points to a possible role for AM3 in the control of the inflammatory response.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.intimp.2005.02.009DOI Listing

Publication Analysis

Top Keywords

expression inos
8
inos induced
8
nitric oxide
8
am3
5
am3 inhibits
4
inhibits lps-induced
4
lps-induced inos
4
inos expression
4
expression mice
4
mice analyzed
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!